Q4 2023 Gland Pharma Ltd Earnings Call Transcript

May 18, 2023 / 01:00PM GMT
Operator

Ladies and gentlemen, good day and welcome to Gland Pharma Limited Q4 FY '23 Earnings Conference Call. (Operator Instructions) Please note that this conference is being recorded.

I now hand the conference over to Mr. Sumanta Bajpayee, Vice President, Finance and Investor Relations. Thank you, and over to you, sir.

Sumanta Bajpayee - Gland Pharma Limited - VP of IR

Thank you. A warm welcome to Gland Pharma's earnings call for fourth quarter and financial year '23. I have with me Mr. Srinivas Sadu, Managing Director and CEO; Mr. Ravi Shekhar Mitra, CFO to discuss business performance and to answer queries during the call.

We will begin the call with business highlights and overview from Mr. Sadu, followed by financial overview by Mr. Mitra. After the opening remarks from management, operator will open the bridge for Q&A session.

Our earnings presentation has been submitted to the stock exchanges, and is also available on our website. Before we proceed with the call, please note some of the statements made in today's discussion may

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot